1. Home
  2. ARES vs ALC Comparison

ARES vs ALC Comparison

Compare ARES & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARES
  • ALC
  • Stock Information
  • Founded
  • ARES 1997
  • ALC 1945
  • Country
  • ARES United States
  • ALC Switzerland
  • Employees
  • ARES N/A
  • ALC N/A
  • Industry
  • ARES Investment Managers
  • ALC Ophthalmic Goods
  • Sector
  • ARES Finance
  • ALC Health Care
  • Exchange
  • ARES Nasdaq
  • ALC Nasdaq
  • Market Cap
  • ARES 35.3B
  • ALC 41.0B
  • IPO Year
  • ARES 2014
  • ALC N/A
  • Fundamental
  • Price
  • ARES $191.48
  • ALC $84.37
  • Analyst Decision
  • ARES Buy
  • ALC Strong Buy
  • Analyst Count
  • ARES 14
  • ALC 14
  • Target Price
  • ARES $166.38
  • ALC $102.53
  • AVG Volume (30 Days)
  • ARES 933.8K
  • ALC 801.5K
  • Earning Date
  • ARES 02-05-2025
  • ALC 02-25-2025
  • Dividend Yield
  • ARES 1.94%
  • ALC 0.31%
  • EPS Growth
  • ARES 0.39
  • ALC 156.61
  • EPS
  • ARES 2.19
  • ALC 2.34
  • Revenue
  • ARES $3,679,765,000.00
  • ALC $9,761,000,000.00
  • Revenue This Year
  • ARES $0.31
  • ALC $5.43
  • Revenue Next Year
  • ARES $34.28
  • ALC $6.42
  • P/E Ratio
  • ARES $87.56
  • ALC $35.98
  • Revenue Growth
  • ARES 4.67
  • ALC 5.25
  • 52 Week Low
  • ARES $113.66
  • ALC $74.30
  • 52 Week High
  • ARES $192.01
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • ARES 65.51
  • ALC 46.68
  • Support Level
  • ARES $171.47
  • ALC $82.31
  • Resistance Level
  • ARES $182.79
  • ALC $83.68
  • Average True Range (ATR)
  • ARES 4.51
  • ALC 1.04
  • MACD
  • ARES 0.92
  • ALC 0.14
  • Stochastic Oscillator
  • ARES 97.42
  • ALC 59.71

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets and Secondaries Group. Its Credit Group generates maximum revenue, and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: